MC1R

In one line: MC1R is the receptor that decides whether your pigment cells make brown, UV-shielding melanin or red — so it sets red hair, fair skin and freckles — but the same loss-of-function reaches into melanoma risk and even into how the body registers pain.

---

The gene

MC1R — the melanocortin-1 receptor — sits near the tip of the long arm of chromosome 16 (band 16q24.3). It encodes a small seven-pass, G-protein-coupled receptor that studs the surface of melanocytes, the cells in your skin and hair that make pigment. Think of it as an antenna: when it fires, the cell makes one kind of pigment; when it stays quiet, the cell makes another. That one decision ripples outward further than anyone expected when the gene was first cloned.

The hunt

The receptor was cloned in 1992 by Ken Mountjoy, Roger Cone and colleagues (and, independently, by Chhajlani and Wikberg the same year) — the first of the melanocortin-receptor family to be pulled out. Three years later, in 1995, a group in Edinburgh — Valverde, Healy, Jackson, Rees and Thody — showed that specific MC1R sequence variants tracked with red hair and fair skin: they turned up in more than 80% of red-haired or poorly-tanning people but in fewer than 20% of those with brown or black hair. It was one of the first clean links between a single gene and ordinary, everyday human pigment variation.

The mechanism

Here is the switch. The hormone α-MSH docks onto MC1R; the activated receptor turns on adenylyl cyclase and raises cyclic-AMP inside the melanocyte. High cAMP tells the cell to make eumelanin — the brown-to-black pigment that absorbs ultraviolet light and shields the DNA in the cells below. But many people carry MC1R variants whose receptor can't relay that signal. With the antenna quiet and cAMP low, the cell falls back to the other pigment — pheomelanin, a red-to-yellow pigment. That fallback is, visibly, red hair, fair skin and freckles.

The stakes, and the frontier

Sun. Pheomelanin is a poor sunscreen, so fair, freckled skin burns where darker skin tans. Worse, work from David Fisher's lab (Mitra et al., Nature 2012) showed in mice that the red pigment itself is part of the problem: in a Braf-driven model, switching off Mc1r promoted melanoma with no UV at all, and removing pheomelanin abolished the effect — a UV-independent, oxidative route to cancer. In people, carrying two red-hair MC1R variants raises lifetime melanoma risk severalfold.

Pain. And then the surprise. Redheads, on average, need more general anesthetic (Liem et al., Anesthesiology 2004, found ~19% more desflurane), and they handle some kinds of pain differently — more sensitive to certain stimuli, yet more responsive to certain opioid painkillers (Mogil and colleagues). The mechanism, worked out in 2021 (Robinson et al., Science Advances), is elegant and not what you'd guess: MC1R loss makes melanocytes secrete less POMC and α-MSH, and with less circulating α-MSH, the brain's own opioid signaling is left less restrained — raising baseline pain thresholds. A gene we filed under "hair color" is quietly setting a dial on pain, from the skin.

Deep history. Why do the variants exist? Away from the strong equatorial sun the constraint to stay dark relaxed, and MC1R became one of the most polymorphic genes we carry (Harding et al. found it nearly invariant in Africa, highly diverse in Europe). Even Neanderthals carried their own loss-of-function variant (R307G; Lalueza-Fox et al., Science 2007) — some of them were probably pale and red-haired, tens of thousands of years before us.

The open thread. There is nothing to cure — red hair is not a disease. The interesting question is protection: if the trouble is a receptor that won't fire, can you raise cAMP some other way and coax fair skin to make protective pigment anyway? In Mc1r-deficient "redhead" mice, topical forskolin (which raises cAMP) did exactly that — a real tan from a cream, with measurable UV protection (D'Orazio et al., Nature 2006). Turning a vulnerability into a defense is the frontier.

Sources

Full claim-by-claim evidence is in references.md. Primary anchors:

• Locus & receptor: NCBI Gene 4157; OMIM 155555; FISH mapping to 16q24.3 — https://omim.org/entry/155555
• Mountjoy et al., melanocortin-receptor cloning, Science 257:1248 (1992) — https://pubmed.ncbi.nlm.nih.gov/1325670/
• Valverde et al., MC1R variants ↔ red hair/fair skin, Nat Genet 11:328 (1995) — https://www.nature.com/articles/ng1195-328
• Mitra et al., UV-independent melanoma via pheomelanin, Nature (2012) — https://www.nature.com/articles/nature11624
• Liem et al., increased anesthetic requirement in redheads, Anesthesiology (2004) — https://pmc.ncbi.nlm.nih.gov/articles/PMC1362956/
• Robinson et al., the red-hair pain mechanism, Science Advances (2021) — https://www.science.org/doi/10.1126/sciadv.abd1310
• Lalueza-Fox et al., a Neanderthal MC1R allele, Science 318:1453 (2007) — https://pubmed.ncbi.nlm.nih.gov/17962522/
• D'Orazio et al., topical forskolin rescues tanning/UV protection, Nature (2006) — https://pubmed.ncbi.nlm.nih.gov/16988713/

Accuracy note: the episode is careful on three easy-to-overstate points. (1) The pain phenotype is mixed — redheads are not simply "less sensitive to pain"; they are more sensitive to some stimuli, more responsive to some opioids, and need more anesthetic. (2) The pain mechanism is melanocyte-driven (reduced α-MSH derepressing central opioids), not "MC1R acting directly in neurons." (3) The UV-independent melanoma route is a mouse-model finding; the narration says it can add to risk, not that it causes melanoma in people without sun.